Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Trans Resveratrol. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101481300B reveals a low-cost Perkin reaction route for trans-polyhydroxy diphenyl ethylene. Enhance supply chain reliability with high-purity pharmaceutical intermediates.
Novel ionic liquid-mediated Heck coupling for trans-resveratrol. High yield, green process, cost-effective manufacturing for pharmaceutical intermediates.
Novel total synthesis of trans-resveratrol via Wittig-Horner. High yield, mild conditions, scalable production for pharmaceutical and nutraceutical applications.
Novel copper-catalyzed decarboxylation route for high-purity resveratrol and pterostilbene intermediates. Reduces steps and eliminates protection groups for cost-effective manufacturing.
Novel industrial method for resveratrol preparation offering cost reduction and scalability for pharmaceutical intermediates manufacturing via efficient condensation.
Patent CN101544591B discloses a mild Wittig-Horner route for (E)-substituted styrenes, offering cost-effective API intermediate manufacturing with high purity.
Patent CN102276426A reveals a novel ligand-free Heck coupling method for trans-resveratrol. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing.